Cancer Communications (Mar 2021)
Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
- Wu‐tong Ju,
- Ying Liu,
- Li‐zhen Wang,
- Jiang Li,
- Guo‐xing Ren,
- Jian Sun,
- Wen‐yong Tu,
- Yong‐jie Hu,
- Tong Ji,
- Wen‐jun Yang,
- Jun Li,
- Yue He,
- Yan‐an Wang,
- Chen‐ping Zhang,
- Lai‐ping Zhong,
- Zhi‐yuan Zhang
Affiliations
- Wu‐tong Ju
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Ying Liu
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Li‐zhen Wang
- Department of Oral Pathology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Jiang Li
- Department of Oral Pathology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Guo‐xing Ren
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Jian Sun
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Wen‐yong Tu
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Yong‐jie Hu
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Tong Ji
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Wen‐jun Yang
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Jun Li
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Yue He
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Yan‐an Wang
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Chen‐ping Zhang
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Lai‐ping Zhong
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- Zhi‐yuan Zhang
- Department of Oral and Maxillofacial‐Head and Neck Oncology Ninth People's Hospital College of Stomatology Shanghai Jiao Tong University School of Medicine Shanghai 200011 P. R. China
- DOI
- https://doi.org/10.1002/cac2.12136
- Journal volume & issue
-
Vol. 41,
no. 3
pp. 279 – 283
Abstract
No abstracts available.
